March 5th Event
“Novel Delivery Systems for mRNA and Vaccines"
"Delivering mRNA with non-immunogenic lipid nanoparticles"
Dr. Niren Murthy
Professor at UC Berkeley
"Epithelial Vaccines: Respiratory, Dermal, and Oral - How they can be
much better than intramuscular vaccines"
Dr. John Patton
Biotechnology Scientist and Entrepreneur
A tenured Marine Biology Professor at University of Georgia in 1984, Dr. Patton is an entrepreneur and drug delivery scientist with extensive experience in the biotech industry and the development of new inhaled medications. Within the inhalation field, after leading the drug delivery team at Genentech (1985-1990) where he helped pioneer inhaled biologics, he founded/co-founded 4 inhalation companies: Inhale/Nektar Therapeutics in 1990, the recipient of the Wall Street Journal’s Medical Innovation of the year in 2006 for Exubera, the first FDA-approved inhaled Insulin; Dance Biopharm (now Aerami Therapeutics) in 2009; InCarda Therapeutics in 2009; and iPharma Limited in 2016 (acquired by Kindeva in 2022). Dr. Patton has more than 110 publications and is (co)inventor of more than 50 patents.
Event Description:
- The event will begin at 5:00 PM with a 45-minute networking reception (including food and drinks) offering a great opportunity to meet peers and engage with professionals from a variety of backgrounds.
- Following the reception, Dr. Patton and Dr. Murthy will deliver two 30-minute (+ 5-10 minutes of Q/A) talks that dive into a variety of delivery systems for mRNA and vaccines that are advancing the field of drug delivery.
- The evening will conclude with ~45 minutes of additional networking, providing a relaxed space to continue conversations and build meaningful connections.
Thursday, March 5, 2026; 5:00 - 7:45 pm PT
Genentech, Building 35, Room 1A, 350 DNA Way
South San Francisco, CA
$10 - regular fee
$5 – Student, Unemployed or Retired
